🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › California › Mountain View

Chronic Lymphocytic Leukemia clinical trials in Mountain View, CA

7 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Stanford Medicine, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

RecruitingPhase 3
  • Stanford Cancer Institute, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277231

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

RecruitingPhase 3
  • Stanford Cancer Institute, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06973187

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

RecruitingPhase 3
  • Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05254743

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

RecruitingPhase 2
  • Palo Alto Medical Foundation Research Institute (PAMFRI), Palo Alto · 5 mi away
  • Stanford Cancer Center, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated May 19, 2026 · NCT06588478

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

RecruitingPhase 2
  • Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT05388006

Chronic Lymphocytic Leukemia trials in other cities

Other studies in Mountain View

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.